#FRPT24 Recap⚡ Our team are all back from this year's FLASH Radiotherapy & Particle Therapy - FRPT Conference in Rome, making now the perfect time for us to reflect on #FRPT24. It was a pleasure to meet with the international #FLASH community at what was a very busy event for our booth. A notable feature of this year's event was the strong representation from North America. It is encouraging to see the potential for collaborations between Europe, the United States, and Canada to contribute to the development of FLASH toward clinical applications. On the third and final day of the conference, the "FLASH Clinical Program in Villejuif" was presented by Antonin Levy from Gustave Roussy. Dr Levy presented the FLASH-CARE platform, to be equipped with two major clinical devices: FLASHKNiFE (since 2023) and FLASHDEEP. This initiative will serve as a foundation for the radiotherapy department's research into FLASH, as well as its future clinical application. As our final congress of the year comes to an end marking 10 years of research into FLASH, we are as excited as ever to see what we will accomplish over the next decade and where #FLASHRadiotherapy will be in 2034!
THERYQ’s Post
More Relevant Posts
-
Belgian medical high-tech at the service of Indian healthcare Indian AIG Hospitals has announced the acquisition of a state-of-the-art Proton Beam Therapy System. The ProteusONE proton therapy system, supplied by the Belgian company IBA, is the most advanced radiotherapy treatment in existence, delivered using the most powerful medical device. IBA (Ion Beam Applications SA) is a medical technology company based in Louvain-la-Neuve, Belgium. The company is a world leader in developing cyclotrons and integrated proton therapy centers. "At AIG Hospitals, our unwavering commitment is to place patients at the heart of everything we do. The acquisition of the Proton Beam Therapy System and the strategic partnership with IBA represents a transformative step forward in our mission to provide cutting-edge, compassionate care," Dr D Nageshwar Reddy, Chairman of AIG Hospitals said. Read more: https://lnkd.in/dQHVDgzk
To view or add a comment, sign in
-
-
The American Radium Society Thoracic Committee developed multidisciplinary consensus guidelines for cardiac toxicity prevention & management for patients undergoing radiotherapy. The report by Amini & colleagues is linked here: https://bit.ly/4iwQSzi #LCSM
To view or add a comment, sign in
-
-
🎥 Watch a recording of our webinar to explore the benefits that CHKS Accreditation has brought to Radiotherapy Departments across the UK. View the full webinar here: https://lnkd.in/eFAAP5XJ Three key takeaways include: ✅Understanding the Accreditation Process for Radiotherapy - moving from ISO only to CHKS' dual award. 📈 Hearing from Mid and South Essex NHS Foundation Trust on the successes of their Radiotherapy department's accreditation journey. 📋 Learning about CHKS' Radiotherapy standards - which are applicable and which are not. 📞 Find out more about how our CHKS quality improvement advisers could assist your organsisation,: https://lnkd.in/dt9sp26Z #CHKS #Accreditation #Radiotherapy #NHS #Healthcare
To view or add a comment, sign in
-
A Latham team led by partners Nathan Ajiashvili and Dan Hoffman represented Cleerly, a leader in advanced cardiovascular imaging, in a US$106 million Series C funding led by Insight Partners. https://lw.link/DAqVZk
To view or add a comment, sign in
-
A Latham team led by partners Nathan Ajiashvili and Dan Hoffman represented Cleerly, a leader in advanced cardiovascular imaging, in a US$106 million Series C funding led by Insight Partners. https://lw.link/UkFhGE
Latham & Watkins Represents Cleerly in US$106 Million Series C Funding Led by Insight Partners
lw.com
To view or add a comment, sign in
-
CDISC is thrilled to announce the publication of the Cardiac Imaging Supplement v1.0 to the Duchenne Muscular Dystrophy Therapeutic Area User Guide. Developed in partnership with the Critical Path Institute (C-Path) Duchenne Regulatory Science Consortium (D-RSC), the document includes new controlled terminology, and SDTM and ADaM examples for several cardiovascular tests (i.e., basic systolic function, late gadolinium enhancement, parametric mapping and circumferential and longitudinal strain). Access the supplement here: https://lnkd.in/eSvhcuB3 #cleardataclearimpact
To view or add a comment, sign in
-
-
C-Path's Duchenne Regulatory Science Consortium is excited to announce the publication of the Cardiac Imaging Supplement to the Duchenne Muscular Dystrophy Therapeutic Area User Guide v1.0, developed in partnership with CDISC. The user guide includes new controlled terminology, and SDTM and ADaM examples for several cardiovascular tests (i.e., basic systolic function, late gadolinium enhancement, parametric mapping and circumferential and longitudinal strain). We are grateful to all D-RSC members including industry members, academic and clinical advisors, government and regulatory advisors, patient advocate advisors, and C-Path staff who contributed to this wonderful effort. Follow this link below to access the cardiac supplement: https://lnkd.in/eSvhcuB3 #CPath #DMD #Duchenne #CDISC #cardiacevent #globalhealth #datasharing #drugdevelopment Ramona Belfiore-Oshan, Diane Corey, Rebecca Baker, Jon Neville, Jonathan Soslow, Kan Hor, Chet Villa, Karin LaPann, Alana St. Clair, Paige Martin Lysandra Gomez Stacy Owen, Collin Hovinga, Eric Camino, Pat Furlong, Heather Fitzpatrick Medlin, Abby Bronson, Joanne Donovan, Dania D'Achille Porco, Divya Reddy, Sara Cazzaniga, Yoichi Egawa, Jane Larkindale, Jennifer Hibma, Qi Shen, Nidal Boulos, PhD, CCRP, Naz Dastgir, Christian De Ford, Maitea Guridi Ormazabal, Alex Murphy, Nadya Masloboeva, James Richardson, Phil Larimer, Tina Liu, Asif Paker, Mark Peterson, Yiting Wang, Arpeat Kaviya, Daniel Paulson, Yetrib Hathout, Hank Mayer, Christopher Spurney, Carol Gregorio, Larry Markham, FAAP, FACC, Karim Wahbi, Beth Kaufman, PhD, Brenda Wong, Erik Henricson, Stefania Mondello, Mindy Cameron, Ryan Russell PhD Adith Thummalapalli, Colin Werth
CDISC is thrilled to announce the publication of the Cardiac Imaging Supplement v1.0 to the Duchenne Muscular Dystrophy Therapeutic Area User Guide. Developed in partnership with the Critical Path Institute (C-Path) Duchenne Regulatory Science Consortium (D-RSC), the document includes new controlled terminology, and SDTM and ADaM examples for several cardiovascular tests (i.e., basic systolic function, late gadolinium enhancement, parametric mapping and circumferential and longitudinal strain). Access the supplement here: https://lnkd.in/eSvhcuB3 #cleardataclearimpact
To view or add a comment, sign in
-
-
NEW ARTICLE ONLINE NOW | Published on 10 January 2025 📝 Evaluating Proton Versus Photon Therapy: A Call for Nuanced Decision‐Making This letter critically evaluates the conclusions drawn by Li et al (doi.org/10.1002/jmrs.773) in their comparison of proton beam therapy (PBT) and photon irradiation for paediatric and young adult patients. While acknowledging the complexities of treatment selection, the authors argue that PBT's benefits, particularly in reducing radiation exposure to organs at risk, should be given greater consideration. The letter calls for a comprehensive, nuanced approach to treatment decisions, emphasizing long-term outcomes and the reduction of potential late effects. ✍️ Peter Gorayski, Hien Le, Frank Saran 🔗 Read Now: https://lnkd.in/gwGBpC5H 👍 Liked this article? Give this post a like and share it with your network. _____________________________________________ Editor in Chief: Cherry Agustin JMRS is the official journal of Australian Society of Medical Imaging and Radiation Therapy (ASMIRT) and New Zealand Institute of Medical Radiation Technology (NZIMRT). #️⃣ Authors & Contributors: Please leave a comment to be tagged in this post.
To view or add a comment, sign in
-
-
The aScope™ 5 Broncho was made for advanced bronchoscopy procedures. Watch as Interventional Pulmonologist, Dr. John Hinze, performs a rigid bronchoscopy with debulking and removal of a large tumor using the aScope 5 Broncho HD. “The ability to rotate like more expensive interventional scopes was also quite advantageous.” Learn more about how the aScope 5 is the best single-use bronchoscope for advanced procedures: https://ow.ly/BCBx50RG644 #bronchoscopy #singleuseendoscopy
To view or add a comment, sign in
-
#CIRSE2024 Tanti appuntamenti per parlare di embolia polmonare e trombosi venosa profonda. #Inari hands on workshop & symposium 👉see you there!
Join us in Lisbon for #CIRSE2024! We're looking forward to meeting you at CIRSE 2024! Join our experts at the Hands-on Workshop on Saturday 14 September and the #Inari Symposium on Sunday 15 September. Learn practical tips and tricks for setting up and running #PE & #DVT programmes, discover which patients are eligible for mechanical thrombectomy treatment and hear the latest clinical updates. Watch this short video as an introduction to the discussion we'll be having on the panel: https://bit.ly/4ej5BLr We look forward to seeing you there! #VascularHealth #InterventionalRadiology #HealthcareInnovation #DVT #PE
To view or add a comment, sign in
-
--
2mo謝謝您分享資訊